• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Other Chemical Reagents Organic Metal Reagents
• Other Chemical Reagents

Introduction to (4-(Trifluoromethoxy)phenyl)magnesium bromide, 0.50 M in THF and Its Applications in Modern Chemical Research

(4-(Trifluoromethoxy)phenyl)magnesium bromide, 0.50 M in THF, is a highly specialized organometallic compound that has garnered significant attention in the field of synthetic chemistry and pharmaceutical research. This compound, characterized by its unique structural and electronic properties, plays a pivotal role in the development of advanced molecular architectures and functional materials. The presence of the trifluoromethoxy group introduces a high degree of lipophilicity and metabolic stability, making it an invaluable reagent in the synthesis of bioactive molecules.

The preparation of this compound involves the reaction of 4-(trifluoromethoxy)phenol with magnesium bromide in an anhydrous tetrahydrofuran (THF) solvent. This process requires stringent conditions to ensure the formation of a stable Grignard reagent. The resulting solution, 0.50 M in THF, is highly reactive and is typically used in subsequent synthetic transformations without further purification. The high concentration ensures efficient utilization in multi-step syntheses, reducing the need for additional reagent handling.

In recent years, (4-(Trifluoromethoxy)phenyl)magnesium bromide has been extensively utilized in the pharmaceutical industry due to its ability to form versatile intermediates. One notable application is in the synthesis of antiviral and anticancer agents. The trifluoromethoxy group enhances the binding affinity of drug candidates to biological targets, improving their efficacy. For instance, studies have demonstrated its utility in constructing novel kinase inhibitors, which are critical in targeted cancer therapies.

The compound's reactivity also makes it valuable in materials science, particularly in the development of organic electronic materials. Researchers have leveraged its ability to form stable organometallic complexes for applications in organic light-emitting diodes (OLEDs) and photovoltaic cells. The introduction of fluorine atoms into molecular structures often enhances electron transport properties, which is crucial for optimizing device performance.

Recent advancements in computational chemistry have further highlighted the importance of (4-(Trifluoromethoxy)phenyl)magnesium bromide. Molecular modeling studies have revealed that the trifluoromethoxy group can significantly influence the conformational dynamics of adjacent functional groups, thereby affecting reaction pathways and product yields. These insights have enabled chemists to design more efficient synthetic strategies and predict the behavior of complex molecular systems.

The pharmaceutical industry has also seen innovative applications of this compound in drug discovery pipelines. Its role as a key intermediate in constructing heterocyclic scaffolds has been particularly noteworthy. Heterocycles are prevalent motifs in many therapeutic agents due to their ability to mimic natural products and interact with biological macromolecules. By incorporating (4-(Trifluoromethoxy)phenyl)magnesium bromide into synthetic routes, researchers can access novel scaffolds with enhanced pharmacological properties.

The environmental impact of using organometallic compounds like (4-(Trifluoromethoxy)phenyl)magnesium bromide has also been a topic of interest. While these compounds offer significant synthetic advantages, their handling requires careful consideration due to their reactivity with moisture and air. However, advances in green chemistry principles have led to more sustainable practices, such as solvent recovery systems and inert atmosphere techniques, which minimize waste and improve safety profiles.

In conclusion, (4-(Trifluoromethoxy)phenyl)magnesium bromide, 0.50 M in THF, is a cornerstone compound in modern chemical research. Its unique properties make it indispensable for developing pharmaceuticals and advanced materials. As research continues to evolve, this compound will undoubtedly play an even greater role in shaping the future of synthetic chemistry and drug discovery.

• 170793-02-9([3-Fluoro-4-(trifluoromethoxy)phenyl]magnesium bromide, 0.5M 2-MeTHF)
• 944470-93-3((2-(Trifluoromethoxy)phenyl)magnesium bromide, 0.50 M in THF)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)